244 related articles for article (PubMed ID: 22789049)
1. Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.
Liberman J
J Law Med Ethics; 2012; 40(2):326-47. PubMed ID: 22789049
[TBL] [Abstract][Full Text] [Related]
2. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
Mackey TK; Liang BA
BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
[TBL] [Abstract][Full Text] [Related]
3. Opportunities and risks of the proposed FCTC protocol on illicit trade.
Liberman J; Blecher E; Carbajales AR; Burke F
Tob Control; 2011 Nov; 20(6):436-8. PubMed ID: 21821819
[TBL] [Abstract][Full Text] [Related]
4. ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS.
Stukina V; Dohnal J; Saloun J
Acta Pol Pharm; 2016 Sep; 73(5):1381-1388. PubMed ID: 29638079
[TBL] [Abstract][Full Text] [Related]
5. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
6. [Counterfeit medicines--Japan and the world].
Sato D
Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
[TBL] [Abstract][Full Text] [Related]
7. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.
Crosbie E; Bialous S; Glantz SA
Tob Control; 2019 Dec; 28(e2):e110-e118. PubMed ID: 30659106
[TBL] [Abstract][Full Text] [Related]
8. The WHO Tobacco Convention: A New Dawn in the Implementation of International Health Instrument? Comment on "The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?".
Durojaye E
Int J Health Policy Manag; 2018 Feb; 7(2):189-191. PubMed ID: 29524944
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.
Mackey TK; Liang BA
Global Health; 2013 Oct; 9():45. PubMed ID: 24131576
[TBL] [Abstract][Full Text] [Related]
10. [International experience in the legal regulation of the circulation of medicines through the prism of the law of the world trade organization].
Pasechnyk OV; Hendel NV
Wiad Lek; 2018; 71(3 pt 2):772-776. PubMed ID: 29783265
[TBL] [Abstract][Full Text] [Related]
11. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures.
Kumar B; Baldi A
Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250
[TBL] [Abstract][Full Text] [Related]
12. Stopping murder by medicine: introducing the Model Law on Medicine Crime.
Attaran A
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):127-132. PubMed ID: 25897071
[TBL] [Abstract][Full Text] [Related]
13. The joint interagency task force and the global steering committee for the quality assurance of health products: two new and proactive approaches promoting access to safe and effective medicines.
Cinnamond M; Woods T
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):133-136. PubMed ID: 26041869
[No Abstract] [Full Text] [Related]
14. [Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain].
Catalán-Matamoros D; González-Ochando N; Pecharroman-Arribas H; Fernández-Muelas A; Bentolila-Benchimol SS; IbarraLorente M
Rev Esp Salud Publica; 2016 Aug; 90():e1-e14. PubMed ID: 27529446
[TBL] [Abstract][Full Text] [Related]
15. Approaches for controlling illicit tobacco trade--nine countries and the European Union.
Ross H; Husain MJ; Kostova D; Xu X; Edwards SM; Chaloupka FJ; Ahluwalia IB;
MMWR Morb Mortal Wkly Rep; 2015 May; 64(20):547-50. PubMed ID: 26020137
[TBL] [Abstract][Full Text] [Related]
16. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
[TBL] [Abstract][Full Text] [Related]
17. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
't Hoen E; Pascual F
J Public Health Policy; 2015 Nov; 36(4):384-9. PubMed ID: 26178809
[TBL] [Abstract][Full Text] [Related]
18. New international protocol adopted to combat illicit trade in tobacco products. Historical consensus--a milestone, for global public health.
Cent Eur J Public Health; 2012 Dec; 20(4):275. PubMed ID: 23441392
[No Abstract] [Full Text] [Related]
19. Progress in combating cigarette smuggling: controlling the supply chain.
Joossens L; Raw M
Tob Control; 2008 Dec; 17(6):399-404. PubMed ID: 18784154
[TBL] [Abstract][Full Text] [Related]
20. Falsification of medical products: criminal law mechanism combating threats to public health.
Gutorova N; Zhytnyi O; Soloviov O
Wiad Lek; 2019; 72(5 cz 1):856-861. PubMed ID: 31175785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
